NV Energy Foundation approves grant for Whittemore Peterson Institute

April 20, 2011, By ThisIsReno:

SUBMITTED NEWS RELEASE

Funds will help the institute continue medical research for neuro-immune diseases

The NV Energy Foundation recently announced their approval of a grant request from the Whittemore Peterson Institute (WPI). The Foundation, which distributes charitable contributions throughout its northern and southern Nevada service territory, granted a two-year, $100,000 total commitment to WPI to help support the comprehensive medical research program.

“The Whittemore Peterson Institute is conducting world-class research right in our own backyard,” said Michael W. Yackira, President and CEO of NV Energy. “We are proud to support their efforts to help improve the lives of those suffering from neuro-immune diseases.”

Scientists at WPI have created a comprehensive research program to bring answers to those who suffer from neuro-immune diseases. Their active collaboration with researchers from around the world has already begun to provide significant answers to these serious and debilitating diseases. A major discovery made by WPI researchers is the association of human gamma retroviruses to those with complex chronic diseases.

“WPI is a beacon of hope for millions suffering from neuro-immune diseases worldwide,” said Annette Whittemore, president and founder of WPI. “The support and commitment from NV Energy will allow us to continue the critical translational work at this institute that is necessary to find answers for patients with these seriously debilitating diseases.”

Last fall, WPI began operations in its new facilities at the Center for Molecular Medicine on the University of Nevada, Reno School of Medicine campus. The new space includes basic research laboratories, a clinical laboratory and comprehensive medical facilities.

For more information regarding WPI please visit www.wpinstitute.org or call 775-682-8250.

About The Whittemore Peterson Institute

The Whittemore Peterson Institute is the nation’s first comprehensive translational research facility dedicated to neuro-immune disease research, treatment, education and outreach.